NDC 0597-0385-86
Trijardy XR 12.5 mg/1
empagliflozin, linagliptin, metformin hydrochloride · TABLET, EXTENDED RELEASE
Trijardy XR is a tablet, extended release containing empagliflozin, linagliptin, metformin hydrochloride at a strength of 12.5 mg/1. Manufactured by Boehringer Ingelheim Pharmaceuticals, Inc..
Key Facts
- Brand Name
- Trijardy XR
- Generic Name
- empagliflozin, linagliptin, metformin hydrochloride
- NDC Code (Package)
0597-0385-86- NDC Code (Product)
0597-0385- Manufacturer
- Boehringer Ingelheim Pharmaceuticals, Inc.
- Strength
- 12.5 mg/1
- Dosage Form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Marketing Status
- Application #
- NDA212614
- Drug Class
- Sodium-Glucose Cotransporter 2 Inhibitor [EPC]; Dipeptidyl Peptidase 4 Inhibitor [EPC]
- Marketing Start
- 04/23/2020
Recall History
No Recall HistoryView Full Drug Page
Trijardy XR — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.